Primary breast cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up-Reference-Cited by-同舟云学术

Primary breast cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up

Published:2009-05 Issue: Volume:20 Page:iv10-iv14
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Kataja V.,Castiglione M.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/20/suppl_4/iv10/344350/mdp114.pdf

Reference18 articles.

1. Estimates of the cancer incidence and mortality in Europe in 2006;Ferlay;Ann Oncol,2007

2. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer;Veronesi;N Engl J Med,2003

3. Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007;Goldhirsch;Ann Oncol,2007

4. Five year results of Intergroup study E5194: local excision alone (without radiation treatment) for selected patients with ductal carcinoma in situ (DCIS);Hughes;San Antonio Breast Cancer Symposium,2006

5. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials;Early Breast Cancer Trialists’ Collaborative Group (EBCTCG);Lancet,2005

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Breast cancer-related lymphedema and recurrence of breast cancer: Protocol for a prospective cohort study in China;PLOS ONE;2023-05-16

2. Association of cyclin-dependent kinase inhibitor 2B antisense RNA 1 gene expression and rs2383207 variant with breast cancer risk and survival;Cellular & Molecular Biology Letters;2021-04-13

3. Trends in pre-operative needle biopsy use in invasive breast cancer diagnosis: a Dutch nationwide population study;Acta Oncologica;2020-10-08

4. Unleash multifunctional role of long noncoding RNAs biomarker panel in breast cancer: a predictor classification model;Epigenomics;2020-07

5. Signal peptide missense variant in cancer-brake gene CTLA4 and breast cancer outcomes;Gene;2020-05